Extracts of liriopsis tuber protect AMPA induced brain damage and improve memory with the activation of insulin receptor and ERK I/II

Phytotherapy Research

Volumn 22, Issue 11, 2008, Pages 1450-1457

  Kim, Sung Jin ^a   Lee, Keun ^b  

^a Kyung Hee University   (South Korea)

^b Life Science Research Institute   (South Korea)

Author keywords

ERK I II; Insulin; Insulin receptor; Liriopsis tuber; Memory; Neuroprotection

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CHOLINESTERASE; INSULIN RECEPTOR; LIRIOPSIS TUBER EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; ENZYME ACTIVITY; HERB; HIPPOCAMPUS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIRIOPE (PLANT); MALE; MEMORY; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PLANT TUBER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANGIOSPERMS; ANIMALS; ANOXIA; AVOIDANCE LEARNING; BRAIN INJURIES; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; MEMORY; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PLANT TUBERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SODIUM NITRITE;

LIRIOPSIS; MUS; RATTUS;

EID: 57349161377     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2475     Document Type: Article

References (54)

1. Adamo M, Raizada MK, LeRoith D. 1989. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol 3: 71-100.
2. Amadoro G, Pieri M, Ciotti et al. 2007. Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: Evidence for the involvement of the delayed rectifier potassium current. Neuropharmacology 52: 1366-1377.
3. Berkeley JL, Gomeza J, Wess J, Hamilton SE, Nathanson NM, Levey AI. 2001. M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Mol Cell Neurosci 18: 512-524.
4. Black MD, Wotanis J, Schilip DE, Hanak SE, Sorensen SM, Wettstein JG. 2000. Effect of AMPA receptor modulators on hippocampal and cortical function. Eur. J. Pharmacol 394: 85-90.
5. Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ. 2006. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neuros Res 84: 1367-1375.
6. Chicoine LM, Bahr BA. 2007. Excitotoxic protection by poly-anionic polysaccharide: evidence of a cell survival pathway involving AMPA receptor-MAPK interactions. J Neurosci Res 85: 294-302.
7. Chung B, Shin M. 1998. Illustrated Dictionary of Folk Medicine. Younglim company: 177-178.
8. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
9. Craig CR, Stitzel RE. 1997. Modern Pharmacology with Clinical Applications, 293-302.
10. Ellman GL, Courtney KD, Andres V, Featherstone RM. 1961. A new and rapid calorimetric determination of acetylcholine-sterase activity. Biochem Pharmacol 7: 88-95.
11. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20: 9235-9241.
12. Gagliardi RJ. 2000. Neuroprotection, excitotoxicity and NMDA antagonists. Arq Neuro-Psiquiatr 58: 583-588.
13. Gerozissis K, Rouch C, Lemierre S, Nicolaidis S, Orosco M. 2001. A potential role of central insulin in learning and memory related to feeding. Cell Mol Neurobiol 21: 389-401.
14. Gibson GE, Blass JP. 1976. Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 27: 37-42.
15. Gibson GE, Shimada M, Blass JP. 1978. Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia. J Neurochem 31: 757-760.
16. Giovannini MG. 2006. The role of the extracellular signal-regulated kinase pathway in memory encoding. Rev Neurosci 17: 619-634.
17. Haloween B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
18. Han Y, Kim SJ. 2003. Memory enhancing actions of Asiasari radix extracts via activation of insulin receptor and extra-cellular signal regulated kinase (ERK) I/II in rat hippocampus. Brain Res 974: 193-201.
19. Han Y, Kim SJ. 2005. Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt). J Neural Transm 112: 1435-1463.
20. Han Y, Kwon EH, Kim SJ. 2003. Protection of brain cells against AMPA-induced damage by Asiasari radix extracts. Phytother Res 17: 882-886.
21. Harlow E, Lane D. 1988. Antibodies: A Laboratory Manual, 726.
22. Harrison NL, Simmonds MA. 1985. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol 84: 381-391.
23. Harborne JB, 1998. Phytochemical Methods, A Guide to Modern Techniques of Plant Analysis. Chapman and Hall: London, 4-7.
24. Heidenreich KA, Toledo SP. 1989. Insulin receptors mediate growth effects in cultured fetal neurons II. Activation of a protein kinase that phosphorylates ribosomal protein S6. Endocrinology 125: 1458-1463.
25. Hill JM, Lasniak MK, Pert CB, Roth J. 1986. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17: 1127-1138.
26. Hipskind RA, Bilbe G. 1998. MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3: 804-816.
27. Hoyer S. 2000. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp Gerontol 35: 1363-1372.
28. Hoyer S. 2002a. The aging brain. Changes in the neuronal insulin-insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 109: 991-1002.
29. Hoyer S. 2002b. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109: 341-360.
30. Hoyer S. 2003. Memory function and brain glucose metabolism. Pharmacopsychiatry 36: S62-S67.
31. Kanellopoulos GK, Xu XM, Hsu CY, Lu X, Sundt TM, Kouchoukos NT. 2000. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 31: 1945-1952.
32. Kou J, Tian Y, Tang Y, Yan J, Yu B. 2006. Antithrombic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol Pharm Bull 29: 1267-1270.
33. Kou J, Yu B, Xu Q. 2005. Inhibitory effects of ethanol extract from Radix Ophiopogon japonicus on venous thrombosis linked with endothelium-protective and anti-adhesive activites. Vasc Pharmacol 43: 157-163.
34. Kumar V, Singh PN, Muruganandan AV, Bhattacharya SK. 2000. Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J Ethnopharmacol 72: 119-128.
35. Lee YC, Lee JC, Seo YB, Kook YB. 2005. Liriopsis tuber inhibit OVA-induced airway inflammation and bronchial hyper-responsiveness in murine model of asthma. J Ethnopharmacol 101: 144-152.
36. Maher P, Akaishi T, Abe K. 2006. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci 103: 16568-16573.
37. Nellgard B, Wieloch T. 1992. Cerebral protection by AMPA-and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 92: 259-266.
38. Olanow CW. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439-444.
39. Park CR. 2001. Cognitive effects of insulin in the central nervous system. Neurosci Behav Rev 25: 311-329.
40. Park CP, Seeley RJ, Craft S, Woods SC. 2000. Intracerebroventricular insulin enhances memory in a passive avoidance task. Physiol Behav 68: 509-514.
41. Peterson C, Gibson GE. 1982. 3, 4-Diaminopyridine alters acetylcholine metabolism and behavior during hypoxia. J Pharm Exp Ther 222: 576-582.
42. Plata-Salaman CR. 1991. Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev 15: 243-258.
43. Schindler U, Rush DK, Fielding S. 1984. Nootropic drugs: Animal models for studying effects on cognition. Drug Dev Res 4: 567-576.
44. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB. 2000. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Behav Rev 24: 855-872.
45. Sweat JD. 2001. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76: 1-10.
46. Tekkok SB, Goldberg MP. 2001. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21: 4237-4248.
47. Thiels E, Klann E. 2001. Extracellular signal-regulated kinase, synaptic plasticity, and memory. Rev Neurosci 12: 327-345.
48. TradiMed. 1999. New Oriental Medicine Index Traditional Medicine Database. Natural Products Research Institute of Seoul National University, revised ed.
49. Unger JW, Livingston JN, Moss AM. 1991. Insulin receptors in the central nervous system: localization, signaling mechanisms and functional aspects. Prog Neurobiol 36: 343-362.
50. Vanhems E, Delbos M, Girardie J. 1990. Insulin and neuroparsin promote neurite outgrowth in cultured locust CNS. Eur J Neurosci 2: 776-782.
51. Watkins JC, Evans RH. 1981. Excitatory amino acid transmitters. Rev Pharmacol Tox 21: 165-204.
52. Weiss JH, Yin HJ, Choi DW. 1994. Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity. Neuroscience 60: 659-664.
53. Yang JW, Raizada MD, Fellows RE. 1981. Effect of insulin in cultured rat brain cells: stimulation of ornithine decarboxylase activity. J Neurochem 36: 1050-1057.
54. Zhao W, Chen H, Xu H et al. 1999. Brain insulin receptors and spatial memory. J Biol Chem 274: 34893-34902.